| Jon Kurtis Olsen, PHARMD | |
|
2201 N Broadwell Ave, Grand Island, NE 68803-2153 | |
| (308) 382-3660 | |
| Not Available |
| Full Name | Jon Kurtis Olsen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2201 N Broadwell Ave, Grand Island, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306098199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12965 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jon Kurtis Olsen, PHARMD 3011 Westside St, Grand Island, NE 68803-2337 Ph: (308) 380-1817 | Jon Kurtis Olsen, PHARMD 2201 N Broadwell Ave, Grand Island, NE 68803-2153 Ph: (308) 382-3660 |
News Archive
Sverica International Management LLC, a private equity investment firm, announced today that it made an additional equity investment in RestorixHealth, a comprehensive wound care management company.
Today, the first key findings from 'PE Confidential', a unique Europe-wide public survey on premature ejaculation (PE), reveal the intense - and in many cases - long years of silent suffering that PE poses on men and their partners. 'PE Confidential' also highlights the significant burden that PE places on couples' relationships and why men are reluctant to seek help, advice and solutions for the condition.
Thanksgiving is a time to be grateful, to be with family and friends and to enjoy good food. A Vanderbilt dietitian says that making sure the food you serve is prepared and stored properly can ensure that everyone has a safe and healthy experience.
Covered California announced today that it has selected VSP Vision Care, the nation's largest healthcare organization by membership, to offer access to vision care coverage for adults throughout the state.
Orexo AB announces successful completion of the initial pharmacokinetic trial in the OX219 project. In the comparative bioavailability study, the OX219 buprenorphine/naloxone sublingual tablet formulation demonstrated favourable profiles compared to the comparator Suboxone®, which is the market leading product for treatment of opioid dependence.
› Verified 7 days ago
Dr. Robert Hugh Bailey, R.P. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Ponderosa Dr, Grand Island, NE 68803 Phone: 402-366-1417 | |
Nicole Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1230 N Webb Rd, Grand Island, NE 68803 Phone: 308-384-2626 | |
Mandy Hurlburt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3501 S Locust St, Grand Island, NE 68801 Phone: 308-381-5859 | |
Kenneth James Swinarski, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 620 W State St, Grand Island, NE 68801 Phone: 308-384-8228 Fax: 308-384-6835 | |
Linda Jean Ecklund, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 W 2nd St, Grand Island, NE 68801 Phone: 308-384-8290 Fax: 308-380-0731 | |
Christian D Mcconnell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1710 W 2nd St, Grand Island, NE 68803 Phone: 308-384-4089 | |
Kyle A Young, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 W 2nd St, Grand Island, NE 68801 Phone: 308-384-8290 |